Author(s):
Ravi Kumar, Sanjeev Saini, Chatter Singh, Bijander Singh, Alimuddin Saifi
Email(s):
Email ID Not Available
DOI:
10.5958/2231-5691.2020.00022.2 
Address:
Ravi Kumar1*, Sanjeev Saini2, Chatter Singh2, Bijander Singh2, Alimuddin Saifi3
1Department of Pharmacy, Bharat Institute of Technology, Meerut
2Mahaveer College of Pharmacy, Meerut
3Department of Pharmacy, Katyayani College of Education, Meerut
*Corresponding Author
Published In:
Volume - 10,
Issue - 2,
Year - 2020
ABSTRACT:
Zaire ebolavirus, more commonly known as Ebola virus (EBOV), is one of six known species within the genus Ebolavirus. Four of the six identified ebolaviruses, including EBOV, cause a severe and often fatal hemorrhagic fever in humans and other mammals, known as Ebola virus disease (EVD). Ebola virus belonging to family Filoviridae is of mainly 5 types and has a high fatality rate in humans and nonhuman primates. Once the more virulent forms enter the human population, transmitted through contact with infected body fluids, can result in major epidemics. It is one of the most virulent pathogens among the viral haemorrhagic fevers, and has been reported up to 90% fatality rate. Mortality is the result of multi-organ failure and severe bleeding complications.
Cite this article:
Ravi Kumar, Sanjeev Saini, Chatter Singh, Bijander Singh, Alimuddin Saifi. Ebola Virus: A Review. Asian J. Pharm. Res. 2020; 10(2):117-119. doi: 10.5958/2231-5691.2020.00022.2
Cite(Electronic):
Ravi Kumar, Sanjeev Saini, Chatter Singh, Bijander Singh, Alimuddin Saifi. Ebola Virus: A Review. Asian J. Pharm. Res. 2020; 10(2):117-119. doi: 10.5958/2231-5691.2020.00022.2 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2020-10-2-12